Home › Cholesterol › Florida › Clearwater
Cholesterol clinical trials in Clearwater, FL
4 studies for Cholesterol are looking for participants at sites in and around Clearwater (within about 30 miles). Open a study to see who can join and how to contact the study team.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- BayCare Medical Group, Clearwater
- Clearwater Cardiovascular Consultants, Clearwater
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
RecruitingPhase 3
- Research Site, Clearwater
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
RecruitingPhase 2
- Tampa Bay Medical Research, Clearwater
Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
RecruitingPhase 1
- Clinical Study Center, Clearwater
About Cholesterol
Your body needs some cholesterol, but too much can raise your risk of heart disease. Know the types (HDL and LDL), and how to lower high cholesterol.
More about Cholesterol on MedlinePlus
Cholesterol trials in other cities
- Washington, DC6 studies
- Hialeah, FL5 studies
- Jacksonville, FL4 studies
- Deltona, FL4 studies
- Richmond, VA4 studies
- Durham, NC4 studies
- Dallas, TX3 studies
- Winston-Salem, NC3 studies
- Chicago, IL3 studies
- Houston, TX3 studies
- New York City, NY3 studies
- Alexandria, VA3 studies
Other studies in Clearwater
- Cardiovascular Disease9 studies
- Lupus8 studies
- Obesity7 studies
- Breast Cancer6 studies
- Heart Failure6 studies
- Non-Small Cell Lung Cancer5 studies
- Atrial Fibrillation5 studies
- Psoriatic Arthritis5 studies
- Coronary Artery Disease5 studies
- Overweight5 studies
- High Blood Pressure4 studies
- Rheumatoid Arthritis4 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.